Molecular characterization of HIV type 1 among HIV-infected respondents in a cohort being prepared for HIV phase III vaccine clinical trials, Western Kenya

AIDS Research and Human Retroviruses

Volumn 27, Issue 3, 2011, Pages 257-264

  Oyaro, Micah ^a,b   Mbithi, John ^a   Oyugi, Fred ^b   Laten, Annette ^c   Anzala, Omu ^b   Engelbrecht, Susan ^c  

^a KENYATTA UNIVERSITY   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RNA;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DRUG EFFICACY; ENVELOPE GENE; FEASIBILITY STUDY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KENYA; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PHASE 3 CLINICAL TRIAL (TOPIC); PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE; RECOMBINANT GENE; RNA EXTRACTION;

ADOLESCENT; ADULT; AIDS VACCINES; BASE SEQUENCE; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; GENES, GAG; GENES, POL; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 79952588246     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0061     Document Type: Article

References (35)

1. UNAIDS, 2009: AIDS epidemic update 2009. http://www.unaids.org/en/ KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp.
2. National AIDS Control Council, Office of the President, Kenya, 2008: UNGASS 2008 Country Report for Kenya.
3. NACC, Nairobi. http://data.unaids.org/pub/Report/2008/Kenya-2008-country- progress-report-en.pdf.
4. Plantier J-C, Leoz, M, Dickerson JE, et al.: A new human immunodeficiency virus derived from gorillas. Nat Med 2009;15:871-872.
5. Poss M, Gosink J, Thomas E, et al.: Phylogenetic evaluation of Kenyan HIV type 1 isolates. AIDS Res Hum Retroviruses 1997;13:493-499. (Pubitemid 27168885)
6. Neilson JR, John GC, Carr JK, et al.: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403. (Pubitemid 29189886)
7. Murray MC, Embree JE, Ramdahin SG, et al.: Effect of hu-man immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1. J Infect Dis 2000; 181:746-749. (Pubitemid 30131852)
8. Lihana RW, Khamadi SA, Kiptoo MK, et al.: HIV type 1 subtypes among STI patients in Nairobi: A genotypic study based on partial pol gene sequencing. AIDS Res Hum Ret-roviruses 2006;22:1172-1177 (Pubitemid 44904270)
9. Khoja S, Ojwang P, Khan S, et al.: Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS ONE 2008;3:e3191.
10. Lihana RW, Khamadi, S, Lwembe, RM, et al.: The changing trend of HIV-1 subtypes in Nairobi. AIDS Res Hum Retro-viruses 2009;25:337-342.
11. Dowling WE, Kim B, Mason CJ, et al.: Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002;16: 1809-1820.
12. Erratum in AIDS 2002;16:2104.
13. Khamadi SA, Ochieng W, Lihana RW, et al.: HIV type 1 subtypes in circulation in northern Kenya. AIDS Res Hum Retroviruses 2005;21:810-814. (Pubitemid 41434187)
14. Yang C, Li M, Shi YP, et al.: Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya. AIDS Res Hum Retroviruses 2004;20:565-574. (Pubitemid 38720971)
15. Khamadi S, Lihana RW, Osman S, et al.: Genetic diversity of HIV type 1 along the coastal strip of Kenya. AIDS Res Hum Retroviruses 2009;25:919-923.
16. Tovanabutra S, Sanders EJ, Graham SM, et al.: Evaluation of HIV type 1 strains in men having sex with men and in fe-male sex workers in Mombasa, Kenya. AIDS Res Hum Retroviruses 2010;26:123-131.
17. Hanke T and McMichael AJ: Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Nat Med 2000;6:951-955.
18. Rayfield MA, Downing RG, Baggs J, et al.: A molecular ep-idemiologic survey of HIV in Uganda. HIV Variant Working Group. AIDS 1998;12:521-527. (Pubitemid 28116162)
19. Swanson P, Devare SG, and Hackett J: Molecular charac-terization of 39 HIV isolates representing group M (subtypes A-G) and group O: Sequence analysis of gag p24, pol in-tegrase, and env gp41. AIDS Res Human Retroviruses 2003;19:625-629. (Pubitemid 36900581)
20. Delwart EL., Shpaer EG, Louwagie J, et al.: Genetic relation-ships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993;262(5137):1257-1261. (Pubitemid 24036090)
21. Pieniazek D, Yang C, and Lal RB: Phylogenetic analysis of gp41 envelope of HIV-1 groups M, N, and O. In: Human Retroviruses and AIDS 1998: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Korber B, Kuiken CL, Foley B, et al., Eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
22. Bachmann MH, Delwart EL, Shpaer EG, et al.: Rapid genetic characterization of HIV-1 from four WHO-sponsored vac-cine evaluation sites using a heteroduplex mobility assay. AIDS Res Hum Retroviruses 1994;10:1343-1351.
23. Larkin MA, Blackshields G, Brown NP, et al.: Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947-2948. (Pubitemid 350162903)
24. Drummond AJ, Ashton B, Cheung M, et al.: (2009). Geneious v4.8, available from http://www.geneious.com.
25. Tamura K, Dudley J, Nei M, and Kumar S: MEGA4: Mole-cular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599. (Pubitemid 47236692)
26. Kimura M: A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120. (Pubitemid 11166431)
27. Zhang M, Schultz A-K, Calef C, et al.: jpHMM at GOBICS: A web server to detect genomic recombinations in HIV-1. Nucleic Acids Res 2006;34:W463-465. (Pubitemid 44529814)
28. Schultz AK, Zhang M, Leitner T, et al.: A jumping profile hidden Markov model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformat 2006;7:265.
29. Abebe A, Kuiken CL, Goudsmit J, et al.: HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Human Retroviruses 1997;13:1071-1075. (Pubitemid 27330095)
30. Hierholzer M, Graham RR, El Khidir I, et al.: HIV type 1 strains from east and west Africa are intermixed in Sudan. AIDS Res Human Retroviruses 2002;18:1163-1166. (Pubitemid 35191779)
31. Land AM, Ball TB, Luo M, et al.: Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants. AIDS Res Hum Retroviruses 2008;24:865-872. (Pubitemid 351871668)
32. Songok EM, Lihana RW, Kiptoo MK, et al.: Identification of env CRF-10 among HIV variants circulating in rural western Kenya. AIDS Res Hum Retroviruses 2003;19:161-165. (Pubitemid 36308054)
33. Louwagie JW, Janssens J, Mascola L, et al.: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
34. Pernas M, Casado C, Fuentes R, et al.: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006;42:12-18. (Pubitemid 43947941)
35. Burke DS: Recombination in HIV: An important viral evo-lutionary strategy. Emerg Infect Dis 1997;3:253-259. (Pubitemid 127431685)